The clinical utility of multimarker RT-PCR in the detection of occult metastasis in patients with melanoma.

作者: B. Taback , D. L. Morton , S. J. O’Day , D.-H. Nguyen , T. Nakayama

DOI: 10.1007/978-3-642-59537-0_8

关键词:

摘要: Cutaneous melanoma is characterized by a high propensity for metastasis. Currently, surgical intervention remains the mainstay of therapy. This approach has proven most beneficial when diagnosis early stage primary lesions. Likewise, patients undergoing resection solitary site metastasis have shown survival advantage. Identification metastatic disease depends predominantly on radiographic techniques requiring presence significant tumor burdens successful imaging. However, at that time, role surgery and/or biochemotherapy may be limited value. Techniques to identify minimal states permit more accurate assessment prognosis. The detection occult cells RT-PCR in blood, lymph nodes, and bone marrow provides one such monitor progression. Single-marker been used as but noted limitations sensitivity specificity based heterogeneity marker expression among tumors well within an individual lesion or multiple lesions patients. We employed multimarker reverse transcriptase polymerase chain reaction assay demonstrates improved over single-marker approach. consequences detecting systemic subclinical remain unknown pending longer-term follow-up. using molecular conjunction with known clinicopathologic prognostic factors provide novel efficient monitoring progression further high-risk diagnosed course.

参考文章(54)
Peter J. Bostick, Donald L. Morton, Roderick R. Turner, Kelly T. Huynh, He-Jing Wang, Robert Elashoff, Richard Essner, Dave S.B. Hoon, Prognostic Significance of Occult Metastases Detected by Sentinel Lymphadenectomy and Reverse Transcriptase–Polymerase Chain Reaction in Early-Stage Melanoma Patients Journal of Clinical Oncology. ,vol. 17, pp. 3238- 3244 ,(1999) , 10.1200/JCO.1999.17.10.3238
Sabine Letellier, Jean Pierre Garnier, Joelle Spy, Bernard Bousquet, Determination of the l-DOPA/l-tyrosine ratio in human plasma by high-performance liquid chromatography: Usefulness as a marker in metastatic malignant melanoma Journal of Chromatography B: Biomedical Sciences and Applications. ,vol. 696, pp. 9- 17 ,(1997) , 10.1016/S0378-4347(97)00206-5
Terry Sarantou, Andrew J. Conrad, Donald L. Morton, Dave S. B. Hoon, Dorcas D. J. Chi, Peter Schmid, Darryl A. Garrison, Melanoma-associated Antigens as Messenger RNA Detection Markers for Melanoma Cancer Research. ,vol. 57, pp. 1371- 1376 ,(1997)
Christine T Kuo, Peter J Bostick, Reiko F Irie, Donald L Morton, Andrew J Conrad, DS Hoon, Assessment of messenger RNA of beta 1-->4-N-acetylgalactosaminyl-transferase as a molecular marker for metastatic melanoma. Clinical Cancer Research. ,vol. 4, pp. 411- 418 ,(1998)
R. A. Ghossein, J. Rosai, M. Brennan, D. Coit, Zuo Feng Zhang, S. Bhattacharya, Yan Wang, A. Houghton, Prognostic significance of peripheral blood and bone marrow tyrosinase messenger RNA in malignant melanoma. Clinical Cancer Research. ,vol. 4, pp. 419- 428 ,(1998)
DD Chi, Randall E Merchant, Robert Rand, Andrew J Conrad, Darryl Garrison, Roderick Turner, Donald L Morton, DS Hoon, Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas. American Journal of Pathology. ,vol. 150, pp. 2143- 2152 ,(1997)
A Zippelius, P Kufer, G Honold, M W Köllermann, R Oberneder, G Schlimok, G Riethmüller, K Pantel, Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow. Journal of Clinical Oncology. ,vol. 15, pp. 2701- 2708 ,(1997) , 10.1200/JCO.1997.15.7.2701
Ilse Bartke, Anja-Katrin Bosserhoff, Rüdiger Hein, Brigitte Kaluza, Martin Kaufmann, Wilhelm Stolz, Reinhard Buettner, Hubert Zirngibl, Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma. Cancer Research. ,vol. 57, pp. 3149- 3153 ,(1997)
D S Hoon, Y Wang, P S Dale, A J Conrad, P Schmid, D Garrison, C Kuo, L J Foshag, A J Nizze, D L Morton, Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. Journal of Clinical Oncology. ,vol. 13, pp. 2109- 2116 ,(1995) , 10.1200/JCO.1995.13.8.2109
Gregory Miliotes, Gary H. Lyman, C. Wayne Cruse, Chris Puleo, John Albertini, David Rapaport, Frank Glass, Neil Fenske, Tom Soriano, Carole Cuny, Nancy VanVoorhis, Douglas Reintgen, Evaluation of new putative tumor markers for melanoma Annals of Surgical Oncology. ,vol. 3, pp. 558- 563 ,(1996) , 10.1007/BF02306089